港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

医美概念股

1,336.516

-29.392-2.15%

涨家数：2

跌家数：8

平家数：3

市盈率：- -

高：1,363.282

开：1,358.591

低：1,319.826

收：1,365.908

成交量：4,150.49万

成交额：8.20亿

市值：2,156.63亿

流通市值：1,626.25亿

数据加载中...

总览新闻资讯

每日卖空追踪 | 康哲药业 11月17日卖空量成交33.3万股，卖空比例为9.09%

康哲药业11月17日主力净流入209.0万元散户资金抛售

7400万元！上海，又一起收购

复星医药：公司与美国梯瓦就在研药物TEV-56278的开发合作如期推进

每日经济新闻

复星医药(600196.SH)控股子公司药品获美国FDA注册批准

昊海生物科技(06826)11月14日斥资182.96万港元回购6.55万股

每日卖空追踪 | 现代牙科 11月14日卖空量成交1000股，卖空比例为0.38%

每日卖空追踪 | 四环医药 11月14日卖空量成交100.6万股，卖空比例为4.19%

复锐医疗科技11月14日主力净流入135.3万元散户资金抛售

港股异动 | 三生制药(01530)再涨近5% 机构称辉瑞707全球临床开展速度超市场预期

一枚稀缺小分子，揭开复星医药新叙事

原研获批五个月，超25家药企抢首仿！

【特约大V】邓声兴：恒指短线有调整压力，二万七关徘徊

卓珈控股(01827.HK)拟11月25日举行董事会会议审批中期业绩

每日卖空追踪 | 时代天使 11月13日卖空量成交8200股，卖空比例为0.73%

每日卖空追踪 | 复星医药 11月13日卖空量成交30.75万股，卖空比例为7.46%

时代天使11月13日遭主力抛售7.3万元

丽丰控股盘中异动临近午盘股价大涨24.44%

港股三生制药涨超6%

每日经济新闻

港股异动 | 三生制药(01530)现涨超6% 辉瑞将707列为核心管线计划启动多项临床研究

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1593/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"医美概念股","latestPrice":1336.5161,"timestamp":1763366893506,"preClose":1365.9082,"halted":0,"volume":41504908,"delay":0,"changeRate":-0.021518,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-29.39209,"latestTime":"11-17 16:00:00","open":1358.591,"high":1363.2819,"low":1319.8256,"amount":819763039.4,"amplitude":0.031815,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1763429400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1763343000000,1763352000000],[1763355600000,1763366400000]],"pbRate":1.936086,"peRate":27.78233,"turnoverRate":0.002007,"increases":2,"decrements":9,"flats":2,"marketCap":215662750200,"floatMarketCap":162625286584},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":1363.2819,"amplitude":0.031815,"preClose":1365.9082,"low":1319.8256,"pbRate":"1.936086","latestPrice":1336.5161,"volume":41504908,"delay":0,"open":1358.591,"prevYearClose":571.87146,"prevWeekClose":1365.908,"prevMonthClose":1288.46,"prevQuarterClose":1308.644,"fiveDayClose":1258.939,"twentyDayClose":1227.28,"sixtyDayClose":1276.591,"secType":"PLATE","market":"HK","turnoverRate":0.002007,"peRate":27.78233,"marketCap":215662750200,"floatMarketCap":162625286584,"timestamp":1763366893506,"nameCN":"医美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":2,"down":8,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584494946","title":"每日卖空追踪 | 康哲药业 11月17日卖空量成交33.3万股，卖空比例为9.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584494946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584494946?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 16:30","pubTimestamp":1763368215,"startTime":"0","endTime":"0","summary":"康哲药业北京时间11月17日，涨0.78%，卖空量成交33.3万股，较上一交易日减少56.3%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163145a6fee497&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163145a6fee497&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BYV24P56.USD","SG9999015952.SGD","IE00BVYPNP33.GBP","SG9999004220.SGD","IE00BVYPNQ40.USD","SG9999015978.USD","LU2488822045.USD","IE00BGHQDM52.EUR","SG9999015986.USD","BK1593","SG9999015945.SGD","IE00BMCWC346.EUR","BK1191","00867"],"gpt_icon":0},{"id":"2584494116","title":"康哲药业11月17日主力净流入209.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2584494116","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584494116?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 16:15","pubTimestamp":1763367348,"startTime":"0","endTime":"0","summary":"11月17日, 康哲药业股价涨0.78%，报收14.15元，成交金额5134.9万元，换手率0.15%，振幅2.56%，量比0.66。康哲药业今日主力资金净流入209.0万元，上一交易日主力净流出42.7万元。该股近5个交易日上涨2.68%，主力资金累计净流入760.3万元；近20日主力资金累计净流入434.7万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117162033950972a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117162033950972a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BVYPNQ40.USD","00867","BK1593","IE00BVYPNP33.GBP","SG9999015952.SGD","SG9999015978.USD","BK1191","IE00BMCWC346.EUR","SG9999004220.SGD","SG9999015986.USD","LU2488822045.USD","IE00BGHQDM52.EUR","SG9999015945.SGD","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"2583565344","title":"7400万元！上海，又一起收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2583565344","media":"张通社","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583565344?lang=zh_cn&edition=fundamental","pubTime":"2025-11-15 18:01","pubTimestamp":1763200909,"startTime":"0","endTime":"0","summary":"昊海生科认为，此次收购有利于增强集团眼科产品的市场竞争力。同期，该公司净利润与人工晶状体产品净利润之和分别约为4116.26万元，2200.62万元及1618.77万元。2024年年报显示，昊海生科实现营收26.98亿元，与2021年至2023年双位数的高增速相比，营收增速大幅滑落至个位数，同比增长仅1.64%。昊海生科2025年三季报显示，其前三季度实现营收19.0亿元，同比下降8.5%；归母净利润3.05亿元，同比下降10.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115181422a6fb4887&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115181422a6fb4887&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06826","BK1161","BK1593"],"gpt_icon":0},{"id":"2583743885","title":"复星医药：公司与美国梯瓦就在研药物TEV-56278的开发合作如期推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2583743885","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583743885?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 17:55","pubTimestamp":1763114145,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：请问公司与美国梯瓦制药战略合作发展进展如何？是否已经盈利模式？复星医药（600196.SH）11月14日在投资者互动平台表示，截至目前，公司与美国梯瓦就在研药物TEV-56278的开发合作如期推进，相关药物于许可区域内尚处临床前阶段。如有后续重大进展，公司将根据上市地规则要求进行披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511143564906882.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511143564906882.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","BK1191","02196","BK1593"],"gpt_icon":0},{"id":"2583576177","title":"复星医药(600196.SH)控股子公司药品获美国FDA注册批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2583576177","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583576177?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 17:06","pubTimestamp":1763111217,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药 发布公告，近日，公司控股子公司上海复宏汉霖生物技术股份有限公司及其控股子公司自主研发的POHERDY1注射液的生物制品许可申请获美国FDA批准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK0060","BK0028","BK0196","BK1515","02196","BK0096","BK0175","BK1191","BK0183","600196","BK0239","BK0188","BK0187","BK1593"],"gpt_icon":0},{"id":"2583575004","title":"昊海生物科技(06826)11月14日斥资182.96万港元回购6.55万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2583575004","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583575004?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 16:57","pubTimestamp":1763110664,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，于2025年11月14日该公司斥资182.96万港元回购6.55万股，回购价格为每股27.78-28.10港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369349.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06826","BK1593","BK1161"],"gpt_icon":0},{"id":"2583639747","title":"每日卖空追踪 | 现代牙科 11月14日卖空量成交1000股，卖空比例为0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583639747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583639747?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 16:30","pubTimestamp":1763109035,"startTime":"0","endTime":"0","summary":"现代牙科北京时间11月14日，跌1.89%，卖空量成交1000股，较上一交易日减少91.67%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511141641259768ff45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511141641259768ff45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03600","BK1583","BK1100","BK1593"],"gpt_icon":0},{"id":"2583571529","title":"每日卖空追踪 | 四环医药 11月14日卖空量成交100.6万股，卖空比例为4.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583571529","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583571529?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 16:30","pubTimestamp":1763109012,"startTime":"0","endTime":"0","summary":"四环医药北京时间11月14日，股价较前一交易日持平，卖空量成交100.6万股，较上一交易日减少67.07%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111416363695041cd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111416363695041cd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","00460","BK1600","BK1191","BK1515"],"gpt_icon":0},{"id":"2583814536","title":"复锐医疗科技11月14日主力净流入135.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2583814536","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583814536?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 16:16","pubTimestamp":1763108162,"startTime":"0","endTime":"0","summary":"11月14日, 复锐医疗科技股价涨0.43%，报收4.64元，成交金额358.3万元，换手率0.16%，振幅4.33%，量比1.50。复锐医疗科技今日主力资金净流入135.3万元，上一交易日主力净流出0万元。该股近5个交易日上涨7.16%，主力资金累计净流入48.3万元；近20日主力资金累计净流出12.9万元，其中净流出天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511141624179768f61c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511141624179768f61c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1585","01696","BK1100"],"gpt_icon":0},{"id":"2583523807","title":"港股异动 | 三生制药(01530)再涨近5% 机构称辉瑞707全球临床开展速度超市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2583523807","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583523807?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 11:51","pubTimestamp":1763092272,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，三生制药再涨近5%，截至发稿，涨4.03%，报35.14港元，成交额11.29亿港元。消息面上，三生制药在2025年STIC会议上公布707联合化疗治疗1LNSCLC的临床2期研究数据。该行认为辉瑞707全球临床开展速度超市场预期，充分体现了FDA对中国创新药的认可，随着ADC联用等后续临床的逐步开展，有望持续催化公司估值提升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369205.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4550","LU0225771236.USD","LU0170899867.USD","LU1066053197.SGD","BK4581","SG9999001176.USD","BK4592","IE00BLSP4452.SGD","BK4534","LU1894683348.USD","LU0289739699.SGD","01530","IE00B19Z3B42.SGD","LU0321505868.SGD","BK1161","LU0321505439.SGD","LU0456855351.SGD","BK1593","BK4533","LU0225284248.USD","LU0306807586.USD","SGXZ57979304.SGD","LU0058720904.USD","LU1066051498.USD","LU1883839398.USD","IE00BBT3K403.USD","IE0002270589.USD","SG9999011175.SGD","LU0122379950.USD","BK4585","LU1023059063.AUD","LU0868494617.USD","BK4588","SG9999003800.SGD","HK0000165453.HKD","LU0985481810.HKD","SG9999002232.USD","BK1583","IE00BLSP4239.USD","LU0234572021.USD","SG9999002224.SGD","LU1894683264.USD","BK4599","IE000M9KFDE8.USD","LU1057294990.SGD","IE00B19Z3581.USD","BK4007","LU0306806265.USD","BK4568"],"gpt_icon":0},{"id":"2583528329","title":"一枚稀缺小分子，揭开复星医药新叙事","url":"https://stock-news.laohu8.com/highlight/detail?id=2583528329","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583528329?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 09:47","pubTimestamp":1763084865,"startTime":"0","endTime":"0","summary":"复星医药的创新叙事，留下了新的注脚。复星医药传递的故事内核简单而有力——芦沃美替尼以双适应症上市，填补罕见肿瘤疾病治疗空白。以这枚稀缺的小分子为新起点，复星医药更多的创新故事正徐徐展开。一方面，芦沃美替尼现已通过2025年医保目录调整初步形式审查，有望进入2026年国家医保目录。潜在稀缺价值持续叠加复星医药全球研发中心正在通过新适应症开发将芦沃美替尼的创新价值推向更高维度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114095720a4a04829&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114095720a4a04829&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","02196","BK1515","BK1191"],"gpt_icon":0},{"id":"2583325528","title":"原研获批五个月，超25家药企抢首仿！","url":"https://stock-news.laohu8.com/highlight/detail?id=2583325528","media":"药融圈","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583325528?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 09:30","pubTimestamp":1763083856,"startTime":"0","endTime":"0","summary":"摩熵医药数据显示，原研获批不久，国内多家明星药企提交了上市申请。瑞维那新于2020年在国内启动临床申报，2024年完成进口上市申报，并于2025年6月正式获批进入中国市场。截图来源：摩熵医药中国药品批文数据库原研药获批仅7日，倍特药业便于6月19日率先申报瑞维那新吸入溶液4类仿制上市。随后齐鲁制药、科伦制药、复星医药等超25家药企竞相入场角逐首仿。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114100904a4a0503b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114100904a4a0503b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1191","02196","BK1515","01477","BK1593","BK1574","BK1161"],"gpt_icon":0},{"id":"2583448195","title":"【特约大V】邓声兴：恒指短线有调整压力，二万七关徘徊","url":"https://stock-news.laohu8.com/highlight/detail?id=2583448195","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583448195?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 09:15","pubTimestamp":1763082920,"startTime":"0","endTime":"0","summary":"恒指短线有调整压力，二万七关徘徊。三生制药2025年中国生物医药企业对外授权交易总额首次突破千亿美元大关，标志着国内创新药企的研发实力已获得国际市场广泛认可，也推动资本市场对具备创新实力的药企重新估值。随着中国创新药持续获得国际市场青睐，三生制药凭藉其扎实的研发管线与成功的国际合作，有望在行业发展浪潮中持续提升其市场价值与竞争地位，为投资者创造长期回报。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/NGExMWIwZjY5YWMzZDJiYjI3NzU4NjU1MjcxMDI5NzU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NGExMWIwZjY5YWMzZDJiYjI3NzU4NjU1MjcxMDI5NzU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1969638","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1237","BK1515","BK1191","01530","BK1161","HHImain","HSI","MHImain","BK4614","IE00BZ08YT58.USD","01177","02833","BK1521","513600","IE00BZ08YR35.GBP","HSImain","BK1589","03692","YANG","MCHmain","06683","HK0000165453.HKD","BK1593","IE00BZ08YS42.EUR","BK1583"],"gpt_icon":0},{"id":"2583550323","title":"卓珈控股(01827.HK)拟11月25日举行董事会会议审批中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2583550323","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583550323?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 17:07","pubTimestamp":1763024829,"startTime":"0","endTime":"0","summary":"格隆汇11月13日丨卓珈控股(01827.HK)宣布，本公司将于2025年11月25日(星期二)举行董事会会议，藉以(其中包括)批准本公司及其附属公司截至2025年9月30日止六个月的中期业绩及其刊发，以及考虑建议派发中期股息(如有)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251113/31792785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1215","BK1593","01827"],"gpt_icon":0},{"id":"2583770562","title":"每日卖空追踪 | 时代天使 11月13日卖空量成交8200股，卖空比例为0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583770562","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583770562?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 16:30","pubTimestamp":1763022639,"startTime":"0","endTime":"0","summary":"时代天使北京时间11月13日，跌1.08%，卖空量成交8200股，较上一交易日减少83.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511131635459501d4fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511131635459501d4fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1100","06699","BK1587","BK1583"],"gpt_icon":0},{"id":"2583652832","title":"每日卖空追踪 | 复星医药 11月13日卖空量成交30.75万股，卖空比例为7.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583652832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583652832?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 16:30","pubTimestamp":1763022630,"startTime":"0","endTime":"0","summary":"复星医药北京时间11月13日，涨1.67%，卖空量成交30.75万股，较上一交易日减少11%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511131634079501d41a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511131634079501d41a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","02196","BK1515","BK1191"],"gpt_icon":0},{"id":"2583030562","title":"时代天使11月13日遭主力抛售7.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583030562","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583030562?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 16:15","pubTimestamp":1763021720,"startTime":"0","endTime":"0","summary":"11月13日, 时代天使股价跌1.08%，报收68.60元，成交金额7813.3万元，换手率0.66%，振幅3.32%，量比1.89。时代天使今日主力资金净流出7.3万元，上一交易日主力净流出27.9万元。该股近5个交易日上涨0.59%，主力资金累计净流入372.5万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入676.5万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113161632a49e7a4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113161632a49e7a4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1593","BK1100","BK1583","06699"],"gpt_icon":0},{"id":"2583559448","title":"丽丰控股盘中异动 临近午盘股价大涨24.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583559448","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583559448?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 11:59","pubTimestamp":1763006386,"startTime":"0","endTime":"0","summary":"2025年11月13日临近午盘11时59分，丽丰控股股票出现异动，股价急速上涨24.44%。截至发稿，该股报1.120港元/股，成交量1.12万股，换手率0.00%，振幅24.44%。丽丰控股股票所在的地产投资行业中，整体跌幅为0.16%。其相关个股中，丽丰控股、太和控股、信基沙溪涨幅较大，振幅较大的相关个股有丽丰控股、太和控股、高山企业，振幅分别为24.44%、24.32%、11.90%。主题公园营运分部于中国内地从事开发及经营主题公园。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113115947a6f5f58f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113115947a6f5f58f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1240","BK1593","01125"],"gpt_icon":0},{"id":"2583535870","title":"港股三生制药涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583535870","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583535870?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 10:04","pubTimestamp":1762999473,"startTime":"0","endTime":"0","summary":"每经AI快讯，三生制药(01530.HK)现涨超6%，截至发稿，涨6.26%，报32.58港元，成交额4.13亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511133563281874.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511133563281874.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["HK0000165453.HKD","BK1593","01530","BK1583","BK1161"],"gpt_icon":0},{"id":"2583533607","title":"港股异动 | 三生制药(01530)现涨超6% 辉瑞将707列为核心管线 计划启动多项临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2583533607","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583533607?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 09:51","pubTimestamp":1762998705,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，三生制药现涨超6%，截至发稿，涨6.26%，报32.58港元，成交额4.13亿港元。消息面上，三生制药在2025年STIC会议上公布707联合化疗治疗1LNSCLC的临床2期研究数据。三生制药的核心产品快速推进全球临床开发，维持“优于大市”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1368625.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BLSP4452.SGD","IE00BLSP4239.USD","LU0306806265.USD","BK4585","LU0289739699.SGD","LU1066051498.USD","SG9999001176.SGD","IE000M9KFDE8.USD","HK0000165453.HKD","BK4588","BK1161","SG9999011175.SGD","LU0321505439.SGD","LU1894683264.USD","LU1066053197.SGD","IE00B19Z3581.USD","SG9999001176.USD","BK4534","BK4007","LU0234572021.USD","BK4568","LU1894683348.USD","BK1583","BK4550","BK4592","SGXZ57979304.SGD","BK4581","BK4599","LU0456855351.SGD","IE0002270589.USD","SG9999002224.SGD","LU0058720904.USD","LU0170899867.USD","LU0225771236.USD","SG9999013999.USD","LU0306807586.USD","LU0321505868.SGD","IE00BBT3K403.USD","LU0868494617.USD","LU0122379950.USD","LU0985481810.HKD","LU1883839398.USD","SG9999003800.SGD","01530","LU1057294990.SGD","LU1023059063.AUD","BK4533","BK1593","IE00B19Z3B42.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":118,"code":"91000000","status":"200"}]}}